BACKGROUND: The Department of Health launched a national human papillomavirus immunisation programme for girls aged 12-13 years in September 2008. AIM: To assess the feasibility and acceptability of implementing a school-based programme. METHOD: HPV vaccination was offered over one academic year by two PCTs in 36 schools to 12-13-year-old girls, using different implementation plans. RESULTS: At parent information evenings, the questions most often raised related to vaccine safety. In PCT 2, first-dose vaccine uptake was 78.7% (1,292), higher than the 59.8% (706) achieved in PCT 1. Using a late recall system and accepting late consenters in PCT 2 was associated with higher uptake, but led to one in five girls being outside the school schedule. CONCLUSION: This study suggests uptake can be improved by achieving a high initial consent rate, accepting late consenters and adopting a flexible policy to maintain high coverage across all three doses.
BACKGROUND: The Department of Health launched a national human papillomavirus immunisation programme for girls aged 12-13 years in September 2008. AIM: To assess the feasibility and acceptability of implementing a school-based programme. METHOD: HPV vaccination was offered over one academic year by two PCTs in 36 schools to 12-13-year-old girls, using different implementation plans. RESULTS: At parent information evenings, the questions most often raised related to vaccine safety. In PCT 2, first-dose vaccine uptake was 78.7% (1,292), higher than the 59.8% (706) achieved in PCT 1. Using a late recall system and accepting late consenters in PCT 2 was associated with higher uptake, but led to one in five girls being outside the school schedule. CONCLUSION: This study suggests uptake can be improved by achieving a high initial consent rate, accepting late consenters and adopting a flexible policy to maintain high coverage across all three doses.
Authors: Jessica A Kadis; Annie-Laurie McRee; Sami L Gottlieb; Morgan R Lee; Paul L Reiter; Patricia J Dittus; Noel T Brewer Journal: Vaccine Date: 2011-02-05 Impact factor: 3.641
Authors: Jennifer L Moss; Ashley L Feld; Brittany O'Malley; Pamela Entzel; Jennifer S Smith; Melissa B Gilkey; Noel T Brewer Journal: J Sch Health Date: 2014-06 Impact factor: 2.118
Authors: Brenda W Stubbs; Catherine A Panozzo; Jennifer L Moss; Paul L Reiter; Dianne H Whitesell; Noel T Brewer Journal: Am J Health Behav Date: 2014-01
Authors: Leah M Smith; Paul Brassard; Jeffrey C Kwong; Shelley L Deeks; Anne K Ellis; Linda E Lévesque Journal: BMC Public Health Date: 2011-08-13 Impact factor: 3.295
Authors: Sarah Perman; Simon Turner; Angus I G Ramsay; Abigail Baim-Lance; Martin Utley; Naomi J Fulop Journal: BMC Public Health Date: 2017-03-14 Impact factor: 3.295
Authors: Rebecca Stretch; Rosemary McCann; Stephen A Roberts; Peter Elton; David Baxter; Loretta Brabin Journal: BMC Public Health Date: 2009-07-21 Impact factor: 3.295